Clinical Symptoms and Haematological Characteristics among Male and Female COVID-19 Patients in Rivers State: A Single-center Case Reviews

Main Article Content

Alali Dan- Jumbo
Tondor Cleopatra Uzosike
Mary Obidiya Okuku

Abstract

Objectives: The study seeks to assess the sex differences in reported clinical symptoms and haematological parameters of hospitalized COVID-19 cases.

Study Design: A retrospective descriptive cross-sectional study.

Place and Duration of Study: Covid-19 Treatment Centre, Rivers State, between May 2020 and July 2020.

Methodology: Descriptive data collection for patients diagnosed of COVID-19 was employed within the months of May to July 2020. A comparison of demographic profile, presenting symptoms, comorbidities and laboratory findings between males and females was analyzed using SPSS version 25. Ethical approval was obtained prior to commencing data collection.

Results: In this study, data of 56 patients were analyzed of which 31 (55.4%) were males and 25 (44.6%) were females. The mean age for all patients was 36 years and males had a higher mean age (40 ± 12.6) compared to females (31 ± 8.8). Twelve patients (21.4%) reported pre-existing co-morbidities and Hypertension 11 (19.6%) was the prevalent co-morbidity followed by peptic ulcer 2 (3.6%) and Diabetes 2 (3.6%) and these were more common among males. Triglyceride level was significantly higher among females (p= 0.028) and low-density lipoprotein (LDL) level was significantly lower among females (p= 0.044) while systolic blood pressure level was significantly higher among males (p= 0.011).

Conclusion: Though similar symptoms and haematological findings occur in males and females, specific disparities in some parameters were observed. We recommend healthcare personnel to consider these differences when caring for patients hospitalized for COVID-19.

Keywords:
COVID-19, sex, symptoms, haematological parameters.

Article Details

How to Cite
Jumbo, A. D.-, Uzosike, T. C., & Okuku, M. O. (2021). Clinical Symptoms and Haematological Characteristics among Male and Female COVID-19 Patients in Rivers State: A Single-center Case Reviews. Asian Journal of Research in Infectious Diseases, 6(1), 8-16. https://doi.org/10.9734/ajrid/2021/v6i130180
Section
Original Research Article

References

Jiang S, Shi Z, Shu Y, Song J, Gao GF, Tan W, Guo D. A distinct name is needed for the new coronavirus. Lancet (London, England). 2020;395(10228):949.

Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung SM, Yuan, et al. Incubation period and other epidemiological characteristics of 2019 Novel Coronavirus Infections with right truncation: A statistical analysis of publicly available case data. J Clin Med. 2020; 9(2):538. DOI: 10.3390/jcm9020538 PMID: 32079150; PMCID: PMC7074197.

Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environmental Research. 2020;13:109819.

World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations; 2020. Available:https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. Accessed 01/07/2020.

European Centre for Disease Prevention and Control. COVID-19 situation update worldwide; 2020. Available:https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases. Accessed; 04/07/2020.

Nigeria Center for Disease Control and Prevention. COVID-19 NIGERIA; 2020. Available:https://covid19.ncdc.gov.ng/report/ Accessed; 04/07/2020.

World Health Organisation. WHO Coronavirus Disease (covid-19) Dashboard; 2020. Available:https://www.covid19.who.int/?gclid= Accessed; 04/12/2020.

World Health Organisation. World Health Data Platform/GHO/countries – Nigeria; 2020. Available:https://www.who.int/countries/nga. Accessed: 04/12/2020.

Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80(6):656-665. DOI: 10.1016/j.jinf.2020.03.041 Epub 2020 Apr 10. PMID: 32283155; PMCID: PMC7151416.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. DOI: 10.1056/NEJMoa2002032 Epub 2020 Feb 28. PMID: 32109013 PMCID: PMC7092819.

Bowale A, Abayomi A, Idris J, Omilabu S, Abdus-Salam I, Adebayo B, Opawoye F et al. Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria. Pan African Medical Journal. 2020;35(2):24. DOI:10.11604/pamj.supp.2020.35.2.23262

Adhikari S, Meng S, Wu Y, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty. 2020;9(29). Available:https://doi.org/10.1186/s40249-020-00646-x

Menni C, Valdes A, Freydin MB, Ganesh S, Moustafa JE, Visconti A, Hysi P, et al. Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection. MedRxiv; 2020.

Advisory Board. Hallucinations, 'Covid toes,' and more: The emerging symptoms of Covid-19; 2020. Available: https://www.advisory.com/daily-briefing/2020/05/20/covid-symptoms. Accessed: 04/07/2020.

Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (Covid-19). Clin Chem Lab Med; 2020.

Vakili S, Savardashtaki A, Jamalnia S, Tabrizi R, Nematollahi MH, Jafarinia M, Akbari H. Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: A literature review. Archives of Medical Research; 2020.

Fan BE, Chong VC, Chan SS, Lim GH, Lim KG, Tan GB, Mucheli SS, Kuperan P, Ong KH. Hematologic parameters in patients with COVID‐19 infection. American journal of hematology. 2020; 95(6):E131-4.

G Lippi, M Plebani. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020; 58:131-1134.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. Pmid:31986264; 2020.

Usman AB, Ayinde O, Akinyode A, Gbolahan A, Bello B. Epidemiology of coronavirus disease 2019 (COVD-19) outbreak cases in Oyo State South West Nigeria, March-April 2020. Pan African Medical Journal. 2020;35(2):88. DOI:10.11604/pamj.supp.2020.35.2.23832

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. pmid:31986264; 2020

Sex, gender and Covid-19. Global Health5050; 2020. Available:https://globalhealth5050.org/covid19/

Nigeria Center for Disease Control. CASE DEFINITIONS FOR COVID-19 (Version 4); 2020. Available:https://ncdc.gov.ng/themes/common/docs/protocols/186_1584531606.pdf. Accessed; 05/07/2020.

Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, Cai J, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS pathogens. 2020;16(4):e1008520.

Chowdhury AT, Karim MR, Mehedi HH, Shahbaz M, Chowdhury MW, Dan G, He S. Analysis of the primary presenting symptoms and hematological findings of COVID-19 patients in Bangladesh; 2020.

Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its impact on patients with COVID-19. SN Compr. Clin. Med. 2020;2: 1069–1076. Available:https://doi.org/10.1007/s42399-020-00363-4

Okoye JO. Attitudinal, regional and sex related vulnerabilities to COVID-19: Considerations for early flattening of curve in Nigeria. Med J Islam Repub Iran. 2020; 34:61. DOI: 10.34171/mjiri.34.61 PMID: 32974227 PMCID: PMC7500420.

Baradaran A, Ebrahimzadeh MH, Baradaran A, Kachooei AR. Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis. Arch Bone Jt Surg. 2020;8(Suppl 1):247-255. DOI: 10.22038/abjs.2020.47754.2346 PMID: 32733980 PMCID: PMC7296605.

World Health Organization. Welcome to the Global Health Observatory. Undated website. As of July. 2010;14.

Daher VB, Oliveira DS, Júnior MF, de Melo Fernandes EJ, de Castro JV, Moya MI, de Castro Guimarães V. Anosmia: A marker of infection by the new corona virus. Respiratory Medicine Case Reports. 2020; 31:101129.

Klopfenstein T, Zahra H, Kadiane-Oussou NJ, Lepiller Q, Royer PY, Toko L, Gendrin V, Zayet S. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on nord franche-comte cluster, France. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases; 2020.

Wang J, Su Y, Wang Q, et al. Sex Differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19 in Beijing. Research Square; 2020. DOI: 10.21203/rs.3.rs-76948/v1

Li J, Zhang Y, Wang F, Liu B, Li H, Tang G, Chang Z, Liu A, Fu C, Gao J. Sex differences in clinical findings among patients with coronavirus disease 2019 (COVID-19) and severe condition. medRxiv; 2020.

Fan J, Wang H, Ye G, Cao X, Xu X, Tan W, Zhang Y. Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism. 2020;107:154243. DOI: 10.1016/j.metabol.2020.154243 Epub 2020 Apr 19. PMID: 32320740. PMCID: PMC7166305.

Aparisi Á, Iglesias-Echeverría C, Ybarra-Falcón C, et al. Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19. medRxiv; 2020. DOI: 10.1101/2020.10.06.20207092